Search Count: 46
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, VOA, SO4 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-11-27 Classification: OXIDOREDUCTASE Ligands: IMP, A1A3K |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2024-09-18 Classification: OXIDOREDUCTASE Ligands: IMP, A1AUF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.16 Å Release Date: 2022-08-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GGU |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2022-08-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GJN |
 |
Taf1-Bd2 In Complex With Cpd27 (6-(But-3-En-1-Yl)-4-(1-Methyl-6-(Morpholine-4-Carbonyl)-1H-Benzo[D]Imidazol-4-Yl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)
Organism: Oryctolagus cuniculus
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2018-11-14 Classification: Transcription/Inhibitor Ligands: G9V |
 |
Taf1-Bd2 In Complex With Cpd8 (6-(But-3-En-1-Yl)-4-(3-(Morpholine-4-Carbonyl)Phenyl)-1,6-Dihydro-7H-Pyrrolo[2,3-C]Pyridin-7-One)
Organism: Oryctolagus cuniculus
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-10-31 Classification: Transcription/Inhibitor Ligands: G9Y |
 |
Crebbp Bromodomain In Complex With Cpd 4 (1-(1-(Cyclopropylmethyl)-3-(1H-Indol-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2018-08-08 Classification: PROTEIN BINDING/INHIBITOR Ligands: DMS, EDO, BKD |
 |
Crebbp Bromodomain In Complex With Cpd3 ((S)-1-(3-(6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9U7 |
 |
Crebbp Bromodomain In Complex With Cpd8 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydrofuran-3-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2018-03-07 Classification: TRANSFERASE/INHIBITOR Ligands: 9UA, DMS, GOL |
 |
Crebbp Bromodomain In Complex With Cpd10 (1-(3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-1-(Tetrahydro-2H-Pyran-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridin-5-Yl)Ethan-1-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9UD |
 |
Crebbp Bromodomain In Complex With Cpd17 (N,2,7-Trimethyl-2,3-Dihydro-4H-Benzo[B][1,4]Oxazine-4-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2018-03-07 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: SO4, 9UG |
 |
Crebbp Bromodomain In Complex With Cpd19 (3-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-N-Methyl-1-(Tetrahydro-2H-Pyran-4-Yl)-1,4,6,7-Tetrahydro-5H-Pyrazolo[4,3-C]Pyridine-5-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2018-02-21 Classification: TRANSCRIPTION REGULATOR/INHIBITOR Ligands: 9U4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-02-21 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: DMS, C2Y |
 |
Crebbp Bromodomain In Complex With Cpd16 (5-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-N-Methyl-1H-Indole-3-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2018-02-21 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: C3J, EDO, NA |
 |
Crebbp Bromodomain In Complex With Cpd17 (5-(7-(Difluoromethyl)-6-(1-Methyl-1H-Pyrazol-4-Yl)-3,4-Dihydroquinolin-1(2H)-Yl)-3-Methylbenzo[D]Thiazol-2(3H)-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2018-02-21 Classification: TRANSFERASE/TRANSFERASE inhibitor Ligands: C3V, SO4, DMS, GOL |
 |
Usp7 In Complex With Cpd2 (4-(3-(1-Methylpiperidin-4-Yl)-1,2,4-Oxadiazol-5-Yl)Phenol)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2017-12-13 Classification: HYDROLASE Ligands: AJJ, GOL |
 |
Cecr2 In Complex With Cpd6 (6-Allyl-N,2-Dimethyl-7-Oxo-N-(1-(1-Phenylethyl)Piperidin-4-Yl)-6,7-Dihydro-1H-Pyrrolo[2,3-C]Pyridine-4-Carboxamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2017-06-14 Classification: Transcription/Inhibitor Ligands: SO4, 96V |
 |
Crystal Structure Of The Bromodomain Of Human Crebbp Bound To Pyrazolopiperidine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.38 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 6XB, DMS |
 |
Crebbp Bromodomain In Complex With Cpd 44 (3-((5-Acetyl-1-(Cyclopropylmethyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridin-3-Yl)Amino)-N-Isopropylbenzamide)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.09 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 6XG, EDO |